JFS Wealth Advisors’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-9
Closed -$399 1957
2022
Q4
$399 Buy
9
+3
+50% +$125 ﹤0.01% 1767
2022
Q3
$0 Buy
6
+3
+100% +$137 ﹤0.01% 1729
2022
Q2
$0 Sell
3
-7
-70% -$332 ﹤0.01% 1727
2022
Q1
$1K Buy
+10
New +$648 ﹤0.01% 1565

Other funds holding ATRC

JFS Wealth Advisors's ATRC Position: Q1 2023 in Review

JFS Wealth Advisors sold out of AtriCure (ATRC) in Q1 2023, closing a stake of 9 shares — an estimated $399 sold.

JFS Wealth Advisors first reported a position in ATRC in Q1 2022 and held it in 4 quarters. The position peaked at $1K in Q1 2022. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2023.

  • JFS Wealth Advisors reported no remaining AtriCure position as of Q1 2023 after selling out during the quarter.
  • JFS Wealth Advisors sold 9 AtriCure shares in Q1 2023, an estimated $399.
  • JFS Wealth Advisors first reported a position in AtriCure in Q1 2022 and held it in 4 quarters.
  • JFS Wealth Advisors's AtriCure position peaked at $1K in Q1 2022.
  • 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2023.

Based on JFS Wealth Advisors's 13F filing for Q1 2023, filed 19 Apr 2023.